SU2C announces researcher-industry collaboration on immunotherapyJuly 13, 2016Genitourinary CancerMelanomaMultiple MyelomaImmuno-oncology
Immunosuppressive regimens did not affect risk of cancer recurrence in meta-analysisJuly 1, 2016OncologyImmuno-oncology
Pembrolizumab paired with immunostimulator is safe and tolerableJune 15, 2016Genitourinary CancerLung CancerImmuno-oncology
Neoadjuvant chemo for advanced ovarian cancer opens ‘window of opportunity’ for immunotherapiesJune 15, 2016Immuno-oncology
NRAS mutations predict immunotherapy outcomes in melanoma patientsMarch 3, 2015MelanomaImmuno-oncology
Systemic Treatment and Outcomes of Metastatic Pancreatic CancerAugust 11, 2014OncologyImmuno-oncology
